Award

Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease

Description: Alzheimer's disease (AD) and related dementias affect a growing number of people as the population ages. Currently, nearly 6 million persons in the US have AD; it is estimated that by the year 2050, that number will be 14 million. With this increase in the number of AD patients, there is a corresponding growth in the number of family members and other caregivers affected by this devastating disease, as well as dramatic social and economic costs. The goal of our research training program is to prepare a new generation of investigators to translate mechanistic scientific discoveries into effective tools for diagnosis, treatment, and prevention of AD and related dementias.
Funding type: training
Funder scheme: T32
Start date: 2016-05-01
End date: 2027-04-30
Investigator: BRIAN C. KRAEMER
Institution: UNIVERSITY OF WASHINGTON
Funded outputs count: 145
Funder award ID: T32AG052354
OpenAlex ID: G9000865440
2026 · C. Andrew Williams, Shannon E. Rose, et al. · Alzheimer s & Dementia · 1
2026 · Katherine R. LeBlanc, Randall J. Eck, et al. · Molecular Neurodegeneration
2026 · Daniel W. Fisher, Ronak Mehta, et al. · Journal of Alzheimer s Disease
2026 · Sarah J. Benbow, Aleen D. Saxton, et al. · bioRxiv (Cold Spring Harbor Laboratory)
2026 · Rafael A. Nafikov, Harkirat K. Sohi, et al. · Genetic Epidemiology
2026 · Deanna L. Plubell, Philip M. Remes, et al. · Molecular & Cellular Proteomics · 5
2025 · Kira Evitts, Emily Turschak, et al. · bioRxiv (Cold Spring Harbor Laboratory)
2025 · Jordan Ogg, Nadia Postupna, et al. · Acta Neuropathologica · 2
2025 · Samantha A. Keil, Deidre Jansson, et al. · Science · 88
2025 · Poonam Trivedi, Katrina Forrest, et al. · Alzheimer s & Dementia · 4
2025 · Katherine R LeBlanc, Randall J Eck, et al. · NAR Molecular Medicine · 4
Year
Topic